David Glenn Koch MD MSCR
Hepatology & Liver Transplantation
Hepatology Section Chief GI Fellowship Associate Program Director of Research Professor, Medicine, Medical University of South Carolina College of Medicine
Join to View Full Profile
25 Courtenay DrCharleston, SC 29425
Phone+1 843-792-6982
Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Medical University of South CarolinaFellowship, Gastroenterology, 2004 - 2007
University of Alabama Medical CenterResidency, Internal Medicine, 2001 - 2004
Louisiana State University School of Medicine in New OrleansClass of 2001
Certifications & Licensure
ME State Medical License 2020 - 2027
SC State Medical License 2004 - 2027
AL State Medical License 2002 - 2004
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Safety Study of Ornithine Phenylacetate to Treat Patients With Acute Liver Failure/Severe Acute Liver Injury Start of enrollment: 2012 Jun 01
- Saroglitazar Magnesium in the Treatment of Non-Alcoholic Steatohepatitis Start of enrollment: 2019 Jun 12
- Sorafenib for Hepatopulmonary Syndrome Start of enrollment: 2014 Mar 01
Publications & Presentations
PubMed
- Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites.Jasmohan S Bajaj, Ethan M Weinberg, K Rajender Reddy, Andrew P Keaveny, Michael K Porayko
Liver Transplantation. 2025-10-01 - 3 citationsObjective Measures of Cardiometabolic Risk and Advanced Fibrosis Risk Progression in Primary Care Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease.Andrew D Schreiner, Jingwen Zhang, William P Moran, David G Koch, Justin Marsden
Endocrine Practice. 2024-11-01 - FIB-4 as a Time-varying Covariate and Its Association With Severe Liver Disease in Primary Care: A Time-dependent Cox Regression Analysis.Andrew D Schreiner, David G Koch, Jingwen Zhang, William P Moran, David G Koch
Journal of Clinical Gastroenterology. 2024-10-01
Journal Articles
- Use of Intra‐Aortic Counterpulsation in Cardiogenic Shock Post‐Liver TransplantationGabriel R Chedister, William D Stoll, Kenneth D Chavin, John W McGillicuddy, Satish N Nadig, David G Koch, Clinical Transplantation
Press Mentions
First Edition: April 23, 2020April 23rd, 2020
Grant Support
- Novel Mechanisms of Hepatopulmonary SyndromeNIH/NHLBI2018–2024
- TARGET-NASH: A 5-year, Longitudinal, Observational Study of Patients with Nonalcoholic Fatty Liver Disease or Nonalcoholic SteatohepatitisTARGET-RWE2016–2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
